Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation

BACKGROUND: It is current practice that patients with hepatocellular carcinoma (HCC) listed for liver transplantation should receive locoregional treatment if the suspected waiting time for transplantation is longer than 6 months, even in the absence of prospective randomized data. Aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Györi, Georg P., Felsenreich, D. Moritz, Silberhumer, Gerd R., Soliman, Thomas, Berlakovich, Gabriela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Original Scientific Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653748/
https://www.ncbi.nlm.nih.gov/pubmed/29104589
http://dx.doi.org/10.1007/s10353-017-0487-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653748/
https://www.ncbi.nlm.nih.gov/pubmed/29104589
http://dx.doi.org/10.1007/s10353-017-0487-8

Ejemplares similares